Bahar Ozdemir

Ankara, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center.

Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center.

Journal: Immunopharmacology and immunotoxicology

Published: December 20, 2022

The Possible Relation of Demodex and Facial Erythema in Connective Tissue Diseases.

The Possible Relation of Demodex and Facial Erythema in Connective Tissue Diseases.

Journal: Iranian journal of parasitology

Published: December 10, 2022

COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.

COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.

Journal: International journal of rheumatic diseases

Published: November 19, 2022

SYSTEMIC SARCOIDOSIS-ASSOCIATED HEPATOCELLULAR CARCINOMA: A CASE REPORT.

SYSTEMIC SARCOIDOSIS-ASSOCIATED HEPATOCELLULAR CARCINOMA: A CASE REPORT.

Journal: Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates

Published: March 01, 2022

Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review.

Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review.

Journal: Immunotherapy

Published: February 14, 2022

De-novo development of fragmented QRS during a six-month follow-up period in patients with COVID-19 disease and its cardiac effects.

De-novo development of fragmented QRS during a six-month follow-up period in patients with COVID-19 disease and its cardiac effects.

Journal: Journal of electrocardiology

Published: January 12, 2022

Semaphorin 3A Levels in Lupus with and without Secondary Antiphospholipid Antibody Syndrome and Renal Involvement.

Semaphorin 3A Levels in Lupus with and without Secondary Antiphospholipid Antibody Syndrome and Renal Involvement.

Journal: Laboratory medicine

Published: December 20, 2021

COVID-19 course in granulomatosis with polyangiitis: single center experience with review of the literature.

COVID-19 course in granulomatosis with polyangiitis: single center experience with review of the literature.

Journal: Turkish journal of medical sciences

Published: October 12, 2021

Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease.

Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease.

Journal: Rheumatology (Oxford, England)

Published: October 05, 2021

Can Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19?

Can Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19?

Journal: Women & health

Published: September 23, 2021

Can anticarbamylated protein antibodies be used to support the diagnosis of systemic lupus erythematosus?

Can anticarbamylated protein antibodies be used to support the diagnosis of systemic lupus erythematosus?

Journal: Biomarkers in medicine

Published: September 07, 2021

Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience.

Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience.

Journal: Future virology

Published: June 19, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026